Clinical Trials Logo

Malignant Cutaneous Melanoma clinical trials

View clinical trials related to Malignant Cutaneous Melanoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03541148 Completed - Clinical trials for Cutaneous Melanoma, Stage III

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Start date: September 16, 2014
Phase: Phase 2
Study type: Interventional

Malignant melanoma, responsible for 75% of deaths from skin cancer. Current therapeutic options have poor response, many adverse events and high costs. For this reason, a study with nutritional supplement Oncoxin-Viusid was carried out. According to previous studies, it has an antitumor, immunomodulatory effect and to potentiate the antiproliferative effect of standard chemotherapeutic agents in different locations and stages of cancer.